LOKI FÜR HUMANISIERTES IMMUNOGLOBULIN

Patent europeic · EP1644417 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1644417
Numer da la dumonda
EP04778633
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-07-2004
Publitgà
12-04-2006
Concedì
30-04-2014
Stritgà
15-07-2024
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 16/46 (2006.01)
Prioritad
US 487733 P 15.07.2003
Dumonda PCT
PCT/US2004/023226 15.07.2004
Publicaziun PCT
WO2005/007696 27.01.2005
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 15-07-2024

    Durada maximala cuntanschida

    Published in Swissreg on 15.07.2024

  2. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  3. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  4. 30-04-2014

    Concedì

    Published in Swissreg on 30.04.2014

Partidas

Possessur

Therapeutic Human Polyclonals, Inc.

3431 Hillview Avenue, Palo Alto, CA 94304, US

Inventur

BUELOW, Roland

Palo Alto, CA 94303, US

VAN SCHOOTEN, Wim

Sunnyvale, CA 94087, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.